A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...
Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...
If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...
GlobalData on MSN2d
Purple Biotech advances NT219 into Phase II recurrent/metastatic SCCHN studyPurple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...
The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback